As GLP-1 receptor agonists move beyond blood sugar and weight loss, a new review shows why clinicians must pair their growing promise with sharper monitoring, safer prescribing, and fairer access
The molecule cycles between its reduced (GSH) and oxidized (GSSG) forms, donating electrons to neutralize reactive oxygen species (ROS) either directly or through glutathione peroxidase-catalyzed reactions
Sone H, Tanaka S, Tanaka S, Iimuro S, Oida K, Yamasaki Y, et al
Researchers found that patients who got the highest dose of the drug lost on average 15.6% of their body weight after 48 weeks, compared to the 2.2% body weight loss seen in patients who got a placebo
A possible explanation for the role of PAPP-A is through increasing the levels of IGFs and their downstream signaling pathway (156)
The creaky feeling in the joints diminishes